BLOG
Optimizing operations in pre-clinical studies, trial design and execution, and expanded indications show promising potential.
How a hidden network of experts can support your strategy with directional insights.
What are the new best practices for engaging KOLs and building successful relationships?
Jason Smith provides his perspective on Daphne Koller’s eye-opening McKinsey interview.
What major trends and market forces point the way to pharma’s future?
What’s new in life science, and how should companies respond?
Our analytics show how upheaval at the social media company may impact the life science industry.
You may be using social monitoring year-round, but there’s value in targeting a specific congress.
It’s here – the definitive list of our most-read blog posts, articles, and resources.
Did 2022 unfold as planned? We check in on our predictions.
